Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
503.51
417.61
485.31
466.32
495.04
412.72
434.46
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
503.51
417.61
485.31
466.32
495.04
412.72
434.46
Raw Material Cost
293.60
269.12
322.86
301.92
303.53
256.56
291.49
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.74
10.69
19.27
9.21
9.96
9.40
9.56
Selling and Distribution Expenses
106.75
86.63
120.93
90.49
98.55
90.81
111.94
Other Expenses
0.74
0.38
1.26
0.51
0.76
0.50
1.07
Total Expenditure (Excl Depreciation)
417.50
370.26
475.69
406.69
419.65
361.80
423.67
Operating Profit (PBDIT) excl Other Income
86
47.300000000000004
9.6
59.6
75.4
50.9
10.8
Other Income
1.98
-5.13
2.76
5.39
5.56
6.21
28.38
Operating Profit (PBDIT)
111.20
65.05
38.51
92.82
98.52
75.78
51.25
Interest
9.74
10.69
19.27
9.21
9.96
9.40
9.56
Exceptional Items
-0.12
-1.10
-14.02
0.00
-0.00
-0.03
-3.00
Gross Profit (PBDT)
209.91
148.49
162.45
164.39
191.51
156.16
142.97
Depreciation
25.84
25.84
30.25
30.25
21.80
21.80
20.09
Profit Before Tax
75.50
27.42
-25.03
53.36
66.77
44.55
18.59
Tax
16.83
5.91
6.40
6.82
7.47
8.66
-1.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
35.06
5.34
-39.34
25.21
46.08
20.83
-0.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
35.06
5.34
-39.34
25.21
46.08
20.83
-0.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
17.68
7.47
-0.04
6.61
8.36
9.13
4.40
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.74
12.82
-39.38
31.82
54.44
29.96
3.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,266.63
1,264.26
1,260.86
1,436.96
1,261.28
1,246.24
1,222.72
Earnings per share (EPS)
0.06
0.01
-0.06
0.04
0.08
0.04
-0.0
Diluted Earnings per share
0.06
0.01
-0.06
0.04
0.08
0.04
-0.0
Operating Profit Margin (Excl OI)
16.56%
10.62%
1.13%
12.26%
14.38%
11.58%
0.64%
Gross Profit Margin
20.13%
12.75%
1.08%
17.93%
17.89%
16.08%
8.9%
PAT Margin
6.96%
1.28%
-8.11%
5.41%
9.31%
5.05%
-0.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 1.72% vs 10.52% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -3.13% vs 24.20% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 17.42% vs 15.53% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -3.00% vs 13.64% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Canature Health Technology Group Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
503.51
0
503.51
Other Operating Income
0.00
0.00
0.00
Total Operating income
503.51
0
503.51
Raw Material Cost
293.60
0
293.60
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
9.74
0
9.74
Selling and Distribution Expenses
106.75
0
106.75
Other Expenses
0.74
0.00
0.74
Total Expenditure (Excl Depreciation)
417.50
0
417.50
Operating Profit (PBDIT) excl Other Income
86.01
0.00
86.01
Other Income
1.98
0
1.98
Operating Profit (PBDIT)
111.20
0
111.20
Interest
9.74
0
9.74
Exceptional Items
-0.12
0
-0.12
Gross Profit (PBDT)
209.91
0
209.91
Depreciation
25.84
0
25.84
Profit Before Tax
75.50
0
75.50
Tax
16.83
0
16.83
Provisions and contingencies
0
0
0.00
Profit After Tax
35.06
0
35.06
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
35.06
0
35.06
Share in Profit of Associates
0
0
0.00
Minority Interest
17.68
0
17.68
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.74
0
52.74
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,266.63
0
1,266.63
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
16.56%
0%
0.00
16.56%
Gross Profit Margin
20.13%
0%
0.00
20.13%
PAT Margin
6.96%
0%
0.00
6.96%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 50.35 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 20.57% vs -13.95% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1.72% vs 10.52% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.27 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 311.72% vs 132.49% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.13% vs 24.20% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.92 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 55.56% vs 96.64% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 17.42% vs 15.53% in Jun 2025
Quarterly - Interest
Interest 0.97 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.35% vs -44.56% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -3.00% vs 13.64% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.56%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
